Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

被引：0
|
作者：
Gasol Cudos, A. [1 ]
Morales Murillo, S. [1 ]
Veas Rodriguez, J. [1 ]
Canosa Morales, C. [1 ]
Mele Olive, J. [1 ]
Vilardell Villellas, F. [1 ]
Sanchez Guzman, D. R. [1 ]
Iglesias Martinez, E. [1 ]
Salud Salvia, A. [1 ]
机构：
[1] Hosp Univ Arnau Vilanova Lleida, Breast Canc Unit, Lleida, Spain
来源：
BREAST | 2019年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P166
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] Correlation of Oncotype Dx Recurrence Score and Luminal Subtypes of Breast Cancer
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Haley, B.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
  • [2] Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer
    Morales Murillo, Serafin
    Gasol Cudos, Ariadna
    Veas Rodriguez, Joel
    Canosa Morales, Carles
    Mele Olive, Jordi
    Vilardell Villellas, Felip
    Sanchez Guzman, Douglas Rene
    Iglesias Martinez, Edelmiro
    Salud Salvia, Antonieta
    BREAST, 2021, 56 : 35 - 41
  • [3] Proposed criteria for luminal A breast cancer accurately predict Oncotype dx™ recurrence score
    Heinemann, F. S.
    BREAST, 2015, 24 : S116 - S116
  • [4] Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
    Galli, Giulia
    Bregni, Giacomo
    Cavalieri, Stefano
    Porcu, Luca
    Baili, Paolo
    Hade, Amash
    Di Salvo, Francesca
    Sant, Milena
    Agresti, Roberto
    Gennaro, Massimiliano
    Folli, Secondo
    De Santis, Maria C.
    Paolini, Biagio
    Carcangiu, Maria L.
    de Braud, Filippo
    Di Cosimo, Serena
    BREAST CARE, 2017, 12 (06) : 391 - 394
  • [5] A population-based propensity score matching analysis of neoadjuvant compared to adjuvant chemotherapy in luminal breast cancer
    Zheng, Chenhui
    Zheng, Danni
    Zhang, Yuzhu
    Lin, Renzhi
    Zheng, Zhibao
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [6] The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer
    Jaime A. Pardo
    Betty Fan
    Alessandra Mele
    Stephanie Serres
    Monica G. Valero
    Isha Emhoff
    Amulya Alapati
    Ted A. James
    Annals of Surgical Oncology, 2021, 28 : 1320 - 1325
  • [7] Role of Oncotype DX® recurrence score in predicting nodal response after neoadjuvant chemotherapy in breast cancer
    Mele, Alessandra
    Alapati, Amulya
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 172 - 172
  • [8] NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN LUMINAL A BREAST CANCERS: RELATIONSHIP WITH ONCOTYPE DX SCORE
    Mhaonaigh, N. Ni
    McAnena, P.
    Kerin, M.
    Brown, J.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 17 - 17
  • [9] Investigating the Role of Oncotype DX in the Treatment of Early Stage Luminal A Breast
    Hughes, L.
    Mcveigh, T.
    Keane, M.
    Sweeney, K.
    Kerin, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 17 - 17
  • [10] Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting
    Robidoux, A.
    McCullough, D.
    Lau, A.
    Stoppler, M.
    Chao, C.
    BREAST, 2017, 32 : S80 - S80
12345